Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 21047225

Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2010 Nov 4
First author
Younes A

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Expert Opin Pharmacother. 2011 Apr;12(6):991-4. doi: 10.1517/14656566.2011.565332.
    note
    Source null
    related pmid
    21405939
    relationship
    Comment in

Authors and identifiers

  1. name
    Younes A
    type
    Author
  2. name
    Bartlett NL
    type
    Author
  3. name
    Leonard JP
    type
    Author
  4. name
    Kennedy DA
    type
    Author
  5. name
    Lynch CM
    type
    Author
  6. name
    Sievers EL
    type
    Author
  7. name
    Forero-Torres A
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Younes A
    type
    Author
  2. name
    Bartlett NL
    type
    Author
  3. name
    Leonard JP
    type
    Author
  4. name
    Kennedy DA
    type
    Author
  5. name
    Lynch CM
    type
    Author
  6. name
    Sievers EL
    type
    Author
  7. name
    Forero-Torres A
    type
    Author
bibliography ids
  1. nci-bib-03589c684dac83ed2ad4db70
book metadata
content sha256
2cba834e6d8d87b2bc6566f0709a57103bca46a106a23ac19ed947b789f44d92
document type
citation
dois
  1. 10.1056/NEJMoa1002965
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:21047225
immutable id
pubmed:21047225@2cba834e6d8d87b2bc6566f0709a57103bca46a106a23ac19ed947b789f44d92
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
19
name
The New England journal of medicine
nlm unique id
0255562
pages
1812-21
volume
363
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Expert Opin Pharmacother. 2011 Apr;12(6):991-4. doi: 10.1517/14656566.2011.565332.
    note
    Source null
    related pmid
    21405939
    relationship
    Comment in
outcomes validated
false
pmid
21047225
provenance
batch id
10a38257e12e9ed1867a
provider
NCBI PubMed ESummary
record sha256
a923ba0d41f847ccf8ddfa4eb3766ffb086f9661c70440a8b99c322ac6f236a3
response sha256
84c4808ca38b35d999cfdf809eb088835175ab38d71586c626096d677096bbcc
retrieved at
2026-09-09T23:46:35.793530+00:00
publication date
display
2010 Nov 4
precision
day
year
2010
publication types
  1. Clinical Trial, Phase I
  2. Journal Article
  3. Multicenter Study
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/21047225/
title
Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas.

Preserved source evidence · Independent clinical review pending · Not medical advice